Document Details
Form
Filing Date
May 1, 2024
Document Date
Apr 29, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.
Filer
Gangloff Scott A.